Literature DB >> 22761266

Use of chemodenervation in dystonic conditions.

Maurice Hanson1.   

Abstract

Dystonia, an uncommon movement disorder that causes sustained muscle contractions and painful body positions, is a difficult diagnostic challenge; misdiagnosis is common. Classification may include etiology, area of physical involvement, or age of onset. Bodily distribution is varied, and dystonias can present as primary (genetic) or secondary (caused by other disease processes or use of neuroleptic drugs). Although there is no cure, the use of botulinum toxins for chemodenervation provides symptomatic relief and is considered the treatment of choice in focal dystonia. The dose of botulinum toxin may be titrated to provide significant relief for 12 weeks or more.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761266     DOI: 10.3949/ccjm.79.s2a.05

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  2 in total

Review 1.  Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms.

Authors:  Bjørnar Hassel
Journal:  Toxins (Basel)       Date:  2013-01-08       Impact factor: 4.546

2.  Dual treatment of hemichorea-hemiballismus syndrome with tetrabenazine and chemodenervation.

Authors:  Chizoba C Umeh; Paige Nichols; Liana S Rosenthal; Zoltan Mari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.